Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Cullinan Therapeutics, Inc. from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Cullinan Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q1 2021 to Q4 2023.
  • Cullinan Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2023 was $872K, a 40.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $872K -$589K -40.3% 31 Dec 2023 10-K 14 Mar 2024
Q3 2023 $872K -$589K -40.3% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $872K 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $872K 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $1.46M +$1.15M +367% 31 Dec 2022 10-K 09 Mar 2023
Q3 2022 $1.46M +$1.15M +367% 30 Sep 2022 10-Q 14 Nov 2022
Q4 2021 $313K 31 Dec 2021 10-K 09 Mar 2023
Q3 2021 $313K 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $313M 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $313K 31 Mar 2021 10-Q 14 May 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.